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Abstract Swine influenza presents a substantial disease burden for pig populations worldwide
and poses a potential pandemic threat to humans. There is considerable diversity in both H1 and
H3 influenza viruses circulating in swine due to the frequent introductions of viruses from humans
and birds coupled with geographic segregation of global swine populations. Much of this diversity
is characterized genetically but the antigenic diversity of these viruses is poorly understood.
Critically, the antigenic diversity shapes the risk profile of swine influenza viruses in terms of their
epizootic and pandemic potential. Here, using the most comprehensive set of swine influenza virus
antigenic data compiled to date, we quantify the antigenic diversity of swine influenza viruses on a
multi-continental scale. The substantial antigenic diversity of recently circulating viruses in different
parts of the world adds complexity to the risk profiles for the movement of swine and the potential
for swine-derived infections in humans.
DOI: 10.7554/eLife.12217.001
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Introduction
Swine have been hypothesized to be a mixing vessel for influenza viruses and were the source of the
2009 H1N1 human pandemic virus (Garten et al., 2009; Smith et al., 2009). The directionality and
relative threat of transmission is generally assumed to be from swine into humans with attention only
recently turning to introductions in the opposite direction – from humans into swine – and the role
that such anthroponotic introductions play in influenza virus evolution (Nelson et al., 2012;
Terebuh et al., 2010). Understanding the dynamics of influenza viruses at the interface between
humans and swine is key for designing optimal surveillance and control strategies.
Currently there are three dominant subtypes of influenza A viruses circulating enzootically in
swine: H1N1, H1N2, and H3N2. The evolutionary history of these viruses reflects multiple introduc-
tions of influenza viruses into swine from other species (Nelson et al., 2012; Vincent et al., 2014;
Grøntvedt et al., 2013; Cappuccio et al., 2011; Ottis et al., 1982; Pereda, 2010; Njabo et al.,
2012; Karasin et al., 2006; Hofshagen, 2009; Holyoake et al., 2011; Forgie et al., 2011;
Pensaert et al., 1981). Much of the work on characterizing swine influenza viruses and their ancestry
has been carried out in the U.S and in Europe (Vincent et al., 2014; Marozin et al., 2002;
Nelson et al., 2014; Simon et al., 2014; Brown et al., 1993; Brown et al., 1997; Brown et al.,
1998; Webby et al., 2000; Webby et al., 2004; Vincent et al., 2009a; Vincent et al., 2009b;
Kyriakis et al., 2011; Watson et al., 2015) with evidence for numerous introductions of human sea-
sonal H1 and H3 influenza viruses into swine since 1990. This pattern continued with the 2009 human
pandemic H1N1 virus (H1N1pdm09) with at least 49 separate human-to-swine transmission events,
some of which appear to have become established in pig populations (Nelson et al., 2012).
eLife digest Influenza viruses, commonly called flu, infect millions of people and animals every
year and occasionally causes pandemics in humans. The immune system can neutralise flu viruses by
recognising the proteins on the virus surface, generically referred to as antigens. These antigens
change as flu viruses evolve to escape detection by the immune system. These changes tend to be
relatively small such that exposure to one flu virus generates immunity that is still effective against
other related flu viruses. However, over time, the accumulation of these small changes can result in
larger differences such that prior infections no longer provide protection against the new virus.
Influenza A viruses infect a wide variety of birds and mammals. Viruses can also transmit from one
species to another, which may result in the introduction of viruses with antigens that are new to the
recipient species and which have the potential to cause substantial outbreaks. Pig flu viruses have
long been considered to be a potential risk for human pandemic viruses and were the source of the
2009 pandemic H1N1 virus. Importantly, humans often transmit flu viruses to pigs. Understanding
the dynamics and consequences of this two-way transmission is important for designing effective
strategies to detect and respond to new strains of flu.
Influenza A viruses of the H1 and H3 subtypes circulate widely in pigs. However, it was poorly
understood how closely related swine and human viruses circulating in different regions were to one
another and how much the antigens varied between the different viruses.
Lewis, Russell et al. have now analysed the antigenic variation of hundreds of H1 and H3 viruses
from pigs on multiple continents. The antigenic diversity of recent swine flu viruses resembles the
diversity of H1 and H3 viruses observed in humans over the last 40 years. A key factor driving the
diversity of the H1 and H3 viruses in pigs is the frequent introduction of human viruses to pigs. In
contrast, only one flu virus from a bird had contributed to the observed antigenic diversity in pigs in
a substantial way.
Once in pigs, human-derived flu viruses continue to evolve their antigens. This results in a
tremendous diversity of flu viruses that can be transmitted to other pigs and also to humans. These
flu viruses could pose a serious risk to public health because they are no longer similar to the current
human flu strains. These findings have important implications not only for developing flu vaccines for
pigs but also for informing the development of more-effective surveillance and disease-control
strategies to prevent the spread of new flu variants.
DOI: 10.7554/eLife.12217.002
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In addition to viruses from humans, avian influenza viruses also occasionally infect swine. Notably,
in 1979, epidemics of an avian H1N1 influenza virus lineage were reported in Belgian swine leading
to the establishment of an ‘avian-like’ H1N1 virus lineage in Europe. This Eurasian avian-like 1C line-
age (Zell et al., 2013) has continued to circulate in swine until the present day, and been introduced
into other geographic areas through international movement of swine (Pensaert et al., 1981;
Zhu et al., 2013; Nelson et al., 2015c). Unsurprisingly, genetic diversity and multi-species origins of
influenza viruses in swine are not restricted solely to pig populations in the U.S. and Europe. China
has the largest swine population of any country and shows similar patterns of frequent introductions
of both H1 and H3 influenza viruses from both avian and human hosts as well as introductions of
swine lineages from other geographic regions (Chen et al., 2014; Vijaykrishna et al., 2011;
Zhu et al., 2011).
Once established in swine, influenza viruses of human or avian origin pose a substantial threat to
swine populations’ health and may spread to other geographically segregated populations
(Nelson et al., 2015c). Similarly, these viruses also pose a threat for introduction or re-introduction
into the human population (Nelson et al., 2014), with associated outbreak and pandemic risks. This
risk is exemplified by the re-introduction of the H3N2v (variant) virus with surface glycoprotein genes
of human origin to over 300 people in 2011–12 from an H3N2 virus that has been endemic in swine
in the U.S. since the late 1990s (Centers for Disease Control and Prevention, 2011;
Bowman et al., 2014).
The influenza virus hemagglutinin (HA) surface glycoprotein is the primary target of the humoral
immune response, undergoes antigenic drift over time, and is the major antigenic constituent in
influenza vaccines used in both humans and livestock. The genetic heterogeneity among the HAs of
influenza viruses circulating in swine in certain geographic regions has been relatively well studied
and characterized (Smith et al., 2009; Nelson et al., 2012; Cappuccio et al., 2011; Nelson et al.,
2015c; Vijaykrishna et al., 2011; Kitikoon et al., 2013; Anderson et al., 2015; Takemae et al.,
2008; 2013; Perera et al., 2013; Pereda et al., 2011). However, the relationships between genetic
diversity and antigenic diversity among contemporary swine influenza viruses and their antigenic sim-
ilarity to human seasonal influenza strains are unknown, largely owing to a lack of antigenic data.
Such antigenic data are critical in assessing the phenotype of the virus, any potential cross-immunity
with viruses circulating in humans and in swine, and the risk of re-emergence from these hosts. These
analyses are also critical in the design of antigenically well-matched vaccines.
In order to help fill this knowledge gap, we compiled the largest and most geographically com-
prehensive antigenic dataset of swine influenza viruses to date. We then used a Bayesian framework
(Bedford et al., 2014) to quantify the antigenic diversity of influenza viruses circulating in humans
and swine thus generating a framework for exploring the antigenic component of risk of introduction
of influenza A viruses from swine into humans and to swine in other geographic regions based on
the antigenic characteristics of swine influenza viruses circulating in different parts of the world.
Results
Dimensionality of influenza virus antigenic evolution in swine
We used hemagglutination inhibition (HI) assays to antigenically characterize a geographically
diverse collection of H1 viruses from swine and humans from 1930–2013 (n=194) and H3 viruses
from swine and humans from 1968–2013 (n=379) and genetically sequenced all antigenically charac-
terized viruses. Of these, 101 H1 and 73 H3 swine influenza viruses were newly characterized for this
study.
In order to accurately quantify the antigenic variation of influenza viruses from swine we first
determined the appropriate number of dimensions for accurately representing their antigenic rela-
tionships. Previous work on quantifying the antigenic evolution of seasonal influenza viruses showed
that the evolution of H3 viruses in humans, as measured in HI assays, could be accurately visualized
in two dimensions (2D) using antigenic cartography (Smith et al., 2004). In contrast, previous work
on swine and equine H3 influenza viruses found that three dimensions (3D) were necessary to accu-
rately visualize antigenic evolution using antigenic cartography (Lewis et al., 2011; 2014; de Jong
et al., 2007; Lorusso et al., 2011). In this study we extensively tested the dimensionality of H1 and
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Figure 1. Evolutionary relationships of H1 (A, B) and H3 (C, D) influenza viruses circulating in swine and humans
inferred by Bayesian Multi-dimensional scaling (BMDS). Each colored ball represents a single virus. Viruses are
colored by lineage (A,C) and by geography (B,D). Lines connecting each virus represent inferred phylogenetic
relationships. Distances for antigenic dimensions are measured in antigenic units (AU) and each unit is equivalent
to a two-fold dilution in HI assay data. Antigenic distance can be interpreted as a measure of antigenic similarity –
viruses close to one another are more antigenically similar than viruses further apart. Interactive visualizations are
available at https://phylogeography.github.io/influenzaH1/ and https://phylogeography.github.io/influenzaH3/.
Source data and GIF files for rotational views of 3D antigenic maps in Figure 1 have been deposited in Dryad
(Lewis et al., 2016).
DOI: 10.7554/eLife.12217.003
Figure 1 continued on next page
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H3 influenza virus antigenic maps and found that the antigenic variation of both virus subtypes was
most accurately represented in three dimensions.
Antigenic diversity of H1 influenza viruses in swine
To investigate the combined antigenic and genetic evolution of our study viruses we implemented a
Bayesian multi-dimensional scaling (BMDS) method for inferring antigenic and genetic relationships
(Bedford et al., 2014). As of 2013, three major H1 lineages circulated in swine: 1. the classical 1A
lineage – descended from the ancestors of the 1918 human influenza pandemic, was first detected
in swine in the 1930’s, and gave rise to the human H1N1pdm09 viruses and swine H1N1pdm09-like
sub-lineage viruses; 2. the human seasonal-like 1B lineage – resulting from multiple introductions
from human seasonal H1 viruses; 3. the Eurasian avian-like 1C lineage – arising from an introduction
from wild birds into swine and first detected in Europe in the 1980’s (Figure 1A, Zell et al., 2013).
Our combined antigenic and genetic analyses of H1 viruses in swine showed an inconsistent rela-
tionship between antigenic clustering and genetic lineage through time with occasional emergence
of new antigenic variants. In all geographic regions for which we had antigenic data we found unique
patterns of antigenic evolution within individual lineages.
In Asia, we observed co-circulation of classical 1A, human seasonal-like 1B, and Eurasian avian-
like 1C lineage viruses. However all three lineages were not detected in any one country. In Hong
Kong – where samples were derived at slaughter from swine sourced from China – classical swine 1A
lineage including the H1N1pdm09 sub-lineage, and Eurasian avian-like 1C lineage viruses were
detected (Figure 1A, light red). For the viruses from Hong Kong, the mean pairwise antigenic dis-
tance (MPD) between the H1N1pdm09 sub-lineage viruses and the two classical 1A lineage clades
was 5.0 and 6.0 AU away (Figure 1—figure supplement 1: Figure 1—figure supplement 2,
Supplementary file 2). The Classical swine 1A lineage viruses collected in Japan (Figure 1A, dark
red) differed from the Hong Kong H1 viruses with a MPD of 5.6 AU. Within the Hong Kong Eurasian
avian-like 1C lineage viruses there were two distinct phylogenetic groups – group 1 and group 2 (as
previously reported in Yang et al. (2016) and Figure 1—figure supplement 1, Supplementary file
2). The Group 1 and Group 2 viruses were 6.5 AU and 4.4 AU (MPD) away from the H1N1pdm09
sub-lineage viruses. The MPD between all Asian and European Eurasian avian-like 1C lineage strains
was 5.2 AU. All of these distances are sufficiently large that it would be surprising if prior infection or
un-adjuvanted vaccines would provide any protection among these virus groups.
In Europe, the Eurasian avian-like 1C lineage co-circulated with the H1N1pdm09 sub-lineage of
classical 1A viruses and the human seasonal-like 1B lineage. The human seasonal-like 1B lineage
viruses were first detected in European swine in the mid-1990’s but have a putative human seasonal
ancestor from the 1980’s. The human seasonal-like 1B viruses differed substantially from the Eurasian
avian-like swine 1C viruses and the H1N1pdm09 sub-lineage viruses (MPD: 6.7 AU and 10.4 AU
respectively). The H1N1pdm2009 sub-lineage viruses also differed substantially from the human sea-
sonal-like 1B lineage viruses (MPD:10.6 AU).
Figure 1 continued
The following figure supplements are available for figure 1:
Figure supplement 1. Figure 1A,B colored by H1 genetic sub lineages in the Bayesian MCC tree.
DOI: 10.7554/eLife.12217.004
Figure supplement 2. Bayesian H1 MCC tree with taxa labels and posterior support values
DOI: 10.7554/eLife.12217.005
Figure supplement 3. Figure 1C,D colored by H3 genetic sub lineages in the Bayesian MCC tree.
DOI: 10.7554/eLife.12217.006
Figure supplement 4. Bayesian H3 MCC tree with taxa labels and posterior support values
DOI: 10.7554/eLife.12217.007
Figure supplement 5. Maximum likelihood phylogenetic trees colored by lineage.
DOI: 10.7554/eLife.12217.008
Figure supplement 6. Maximum likelihood H1 phylogenetic tree with taxa labels and bootstrap support values
DOI: 10.7554/eLife.12217.009
Figure supplement 7. Maximum likelihood H3 phylogenetic tree with taxa labels and bootstrap support values.
DOI: 10.7554/eLife.12217.010
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In Canada, only the classical swine 1A lineages viruses and H1N1pdm09 sub-lineage viruses were
detected. Most of the viruses within the classical swine 1A lineage were antigenically similar to each
other but differed from H1N1pdm09 sublineages viruses with a MPD of 6.5 AU. However, the alpha
sub-lineage of classical 1A lineage viruses (Figure 1B green, Supplementary file 2) antigenically
diverged in Canadian swine to form a separate antigenic group with a MPD of 7.0 AU from the
H1N1pdm09 strains and 4.2 AU from the other Canadian classical swine 1A lineage viruses.
In the USA, the classical swine 1A lineage viruses co-circulated with the H1N1pdm09 sub-lineage
and the human seasonal-like 1B lineage viruses. In the USA the human seasonal-like 1B lineage
viruses evolved two sub-lineages – Delta 1 and Delta 2 (Figure 1—figure supplement 1,
Supplementary file 2) – likely as the result of two separate but nearly contemporaneous introduc-
tions into swine first detected in the early 2000’s. The Delta 1 and 2 sub-lineage viruses antigenically
differed from the H1N1pdm2009 lineage viruses with an MPD of 7.8 AU. Representatives of alpha
sub-lineage of the classical swine 1A lineage in the USA were 7.0 AU (MPD) from the H1N1pdm2009
sub-lineage viruses. The beta and gamma sub-lineages of the classical swine 1A lineage were 6.6
and 4.7 AU (MPD) respectively from the H1N1pdm2009 viruses.
To assess the risk of virus introduction associated with moving live swine between continents we
compared the MPDs of swine influenza H1 viruses circulating in different parts of the world. The
human seasonal-like 1B viruses circulating in European swine were on average 11.7 AU (MPD) from
the human seasonal-like 1B viruses in USA swine. The Eurasian avian-like 1C lineage viruses were 6.8
AU (MPD) from the human seasonal-like 1B lineage viruses in the USA.
Antigenic diversity of H3 influenza viruses in swine
Just as for the H1 viruses, we used BMDS (Bedford et al., 2014) to investigate the antigenic and
genetic evolution of H3 viruses (Figure 1C,D). In European swine there were four H3 introductions
included in our antigenic characterization (Figure 1—figure supplement 3: Figure 1—figure sup-
plement 4). Of these, the European 3A lineage (A/Port Chalmers/1973-like) introduction was the
most commonly detected lineage, showing evidence for three sequential antigenic clusters and
evolving on a markedly different path from the putative ancestor in humans (Figure 1C,D [blue]). A
separate introduction from humans into swine of an antigenically distinct 1970’s-like human seasonal
virus also circulated in European swine in the 1980s and 1990s (Figure 1—figure supplement 1
[Europe 2 Introduction]). The earliest strain in the European 3A lineage was 6.5 AU from the A/Port
Chalmers/1973 reference strain (Figure 1C large grey) and the most recent strain was 9.8 AU
(Supplementary file 2). The distance from our representative of recent human seasonal H3 viruses
(A/Victoria/361/2011) to the H3 European virus in swine and was 14.9 AU (MPD).
In the USA, we found evidence for three H3 virus introduction events from humans into swine in
the mid-1990’s, one of which resulted in the establishment of the 3B lineage (Figure 1C,D) which
became the most frequently detected lineage in swine through 2013, and gave rise to the H3N2v
viruses which infected >300 humans in the US from 2011–2012 (Centers for Disease Control and
Prevention, 2012). We only antigenically characterizes a single representative of the H3N2v viruses
– A/Indiana/8/2011 – and found that it differed from A/Victoria/361/2011 by 6.4 AU (Figure 1 pink).
The MPD between the swine H3 viruses circulating in the USA and in Europe was 12.6 AU.
In Asia we found evidence for multiple introductions of H3 viruses and subsequent antigenic drift
from the six representative viruses in our dataset including an introduction likely mediated by trans-
location of a virus circulating in USA swine to Asian swine (Nelson et al., 2015d). Two separate
introductions from humans were detected in Japan that resulted in circulation in swine beyond the
time of circulation of the ancestral strain in humans. The introductions were ~5.2 AU from A/Victoria/
361/2011 and 10.9 AU (MPD) from the H3 strains circulating in European swine. The most recent
seasonal human H3 introduction detected in Asia was from Vietnam and this virus was 3.8 AU away
from A/Victoria/361/2011 (Supplementary file 2).
Rates of antigenic drift in swine
To investigate the rates of swine influenza virus antigenic drift away from the most recent common
ancestor for each genetic lineage in each geographic region we used TimeSlicer available in SPREAD
(Bielejec et al., 2011). For H1 viruses in swine, the classical 1A lineage evolved at a mean rate of
0.15 AU per year from the earliest antigenically characterized representative in the dataset (A/swine/
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Iowa/15/1930) (Figure 2A, Supplementary file 3). The human seasonal-like 1B viruses introduced
into European swine evolved at a mean rate of 0.17 AU per year (Figure 2B, Supplementary file 3).
The introductions of human seasonal H1 viruses into USA swine that gave rise to the Delta-1 and
Delta-2 lineages showed slightly different rates of antigenic drift – 0.63 for Delta-1 and 0.85 for
Delta-2 – both significantly faster than the human seasonal introduction in European swine
(Figure 2B, Supplementary file 3) but they were only observed over a relatively short time period.
The Eurasian avian-like swine 1C lineage evolved at a mean rate of 0.15 AU per year (Figure 2C,
Supplementary file 3). With the exception of the human seasonal-like 1B lineage viruses in the USA,
the overall antigenic diversity of H1 viruses in swine remained remarkably constant over the study
period (Figure 2A,B,C). The antigenic diversity of the Delta-1 and Delta-2 sublineages in the USA
began to expand rapidly around 2009 for reasons that remain to be elucidated (Figure 2B).
For H3 viruses, we found that the 3B lineages viruses in USA swine evolved antigenically at a
faster rate than the H3 viruses introduced into European swine (0.49 AU per year vs 0.28 AU per
year [Figure 2D,E, Supplementary file 3]). Additionally, the antigenic diversity of H3 viruses in USA
swine, particularly since 2010, has increased at a faster rate than that of H3 viruses in Europeans
swine. Thus sustained circulation of antigenic drift variants within US swine has substantially
increased the observed antigenic diversity in this lineage relative to the observed antigenic diversity
in other geographic regions.
Figure 2. Time series of year-to-year rates of antigenic drift distance and antigenic diversity of H1 and H3 viruses
in swine by genetic lineage. Solid colored lines represent year-to-year antigenic drift distance, where drift for year i
is measured as the mean of Euclidean distances among strains in a phylogenetic lineage in year i compared to the
mean of Euclidean distances among strains of that phylogenetic lineage from the previous year (i–1). The dotted
line represents antigenic diversity among H1 and H3 strains by lineage through time. For the solid and dotted
lines, the shaded region represents the range of the highest posterior density estimates. Multiple introductions
which circulate for >5 years of the human seasonal-like swine H1 lineage in European (purple) and USA (gold)
swine were calculated separately. Source data for Figure 2 has been deposited in Dryad (Lewis et al., 2016).
DOI: 10.7554/eLife.12217.011
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Additional antigenic diversity can be inferred from genetic sequence
data
In addition to the BMDS analyses of viruses for which we had both antigenic and genetic data, we
also performed large-scale phylogenetic analyses of publicly available swine influenza virus
sequence. Through these analyses we inferred potentially important gaps in the global antigenic
data that suggest our antigenic dataset underrepresents the true global antigenic diversity of swine
influenza viruses.
For H1 viruses that circulated in swine as of 2013, we find that the major genetic lineages have
been captured in this study (Figure 1—figure supplement 5: Figure 1—figure supplement 6).
However, new genetic evidence recently became available to demonstrate additional human sea-
sonal introductions into swine in previously under-surveilled regions such as Central and South Amer-
ica (Nelson et al., 2015a; Diba´rbora et al., 2013; Nelson et al., 2015b) (Figure 1—figure
supplement 5). Since genetic lineage does not always predict antigenic phenotype, we cannot make
any inferences about their antigenicity.
Even in cases where we have antigenically-characterized clade representatives, the long branch
lengths associated with some introductions could conceal antigenic drift away from the characterized
clade representatives. The markedly different evolutionary patterns seen in the H3 lineages charac-
terized in swine and the inferred antigenic profile of the viruses introduced to swine, suggests that
the true diversity of H3 viruses circulating in swine is likely to be substantially greater than the diver-
sity found in our BMDS analyses. In particular, we identified 19 additional examples of introductions
of seasonal H3 viruses from humans in 10 countries (Figure 1—figure supplement 5 – black tips:
Figure 1—figure supplement 7). Based on the likely time of these introductions from humans into
swine we estimate that the introduced viruses represent at least 12 distinct antigenic variants based
on the antigenic variation of their human seasonal influenza ancestors. Similar to the H1 genetic line-
ages described above, these additional H3 lineages also require antigenic testing to interpret the
impact of these introductions on the global antigenic diversity of IAV in swine.
Risk posed by swine influenza viruses to the humans
In addition to the challenge the observed antigenic diversity poses to swine populations, the anti-
genic diversity of swine influenza viruses also creates substantial risks for human populations. The
outbreak and pandemic potential of swine influenza viruses in humans is at least partially determined
by human population immunity against swine viruses. This component of risk can be inferred from
the antigenic distance of swine influenza viruses to seasonal viruses or vaccine strains in humans to
which humans are likely to have immunity. Importantly, individuals are unlikely to have immunity to
viruses that only circulated before they were born (Fonville et al., 2014).
Since most of the current swine influenza viruses are the product of human seasonal influenza
virus introductions into swine, we anticipate at least some cross-protective immunity in the human
population that could potentially interfere with re-introduction of these viruses. For example, the
H1N1pdm09 viruses circulating in both humans and swine are very similar antigenically and likely
induce at least some cross-immunity in both hosts (Figure 1A,B). However, for the H1 1C, H3 3A,
and H3 3B human seasonal lineages in swine, the risk of re-introduction into the human population
increases with the proportion of the human population that were born after the human precursor
virus circulated in humans and is amplified by antigenic evolution of these viruses in swine. Thus, in
terms of antigenic similarity and likely prior exposure, earlier introduced lineages of human H1 and
H3 viruses – particularly those with precursors antigenically similar to the H3 1968 pandemic strain –
pose the greatest current risk to humans because of the low or negligible predicted levels of cross
immunity in individuals born since the 1970s. In comparison, the H3N2v viruses, which ultimately
derive from a human seasonal virus introduction in the 1990s, have predominantly infected people
born after the mid-1990s.
Discussion
In this study we characterized the antigenic diversity H1 and H3 viruses circulating in both swine and
humans on a multi-continental scale. The observed diversity was largely driven by frequent introduc-
tions of variants from humans into swine and subsequent antigenic evolution within swine combined
Lewis et al. eLife 2016;5:e12217. DOI: 10.7554/eLife.12217 8 of 17
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with long-term geographic segregation of multiple virus lineages. Much of the antigenic evolution of
human-origin viruses in swine was via long and divergent evolutionary paths from those observed in
humans. These divergent paths create threats for the re-introduction of viruses into humans as well
as the possibility for antigenically novel strains in humans to be introduced into swine. Interestingly,
the introduction of viruses from birds to swine has made only one major contribution to the antigenic
diversity of influenza viruses in swine. This could be at least partially due to the antigenic similarity of
the avian-like and the classical swine 1A lineages found here, although an exhaustive test of anti-
genic similarity between avian and swine H1 and H3 viruses could not be performed as part of this
study and to the best of our knowledge has not been reported elsewhere. Successful introduction of
avian influenza viruses into swine will also likely be influenced by other factors including mutations
conferring adaption for mammalian transmission (Herfst et al., 2012; Imai et al., 2012) and other
physiological and ecological factors.
In addition to multiple introduction events and subsequent antigenic drift, the patterns of anti-
genic diversity and heterogeneity among geographic regions are also influenced by the relative geo-
graphic isolation of swine populations resulting in region-specific patterns of virus evolution and
circulation. The observed patterns of antigenic heterogeneity among geographic regions are also
likely influenced by livestock production system differences, particularly regional differences in the
movement of swine within and between animal holdings. USA producers commonly move swine
among otherwise geographically isolated areas at different ages after weaning, whereas in the EU
there is negligible intra- or inter-country movement of animals during a single production cycle. Such
livestock movement patterns have been shown to influence the evolution of influenza viruses in
swine in the USA, with the Midwest serving as an ecological sink for swine influenza virus with the
source of genetic diversity located in the south east and south central states for some HA lineages
(Nelson et al., 2011).
Vaccination is used extensively as a means to control influenza in swine in the USA and sporadi-
cally globally. Control strategies vary by region with some countries having no swine influenza vac-
cine usage, while others produce autologous (herd specific) vaccine for individual producers, which
may be used consecutively with commercially-manufactured multi-strain vaccine when a new out-
break strain requires an update to vaccine composition. Most autologous and commercial products
are multivalent due to the diversity of circulating strains. However, there is no formalized system for
matching vaccine strains with circulating strains, nor validated protocols for standardization and
effective vaccine use. The antigenic diversity quantified here is sufficiently large that it is highly
unlikely that one strain per subtype would be efficacious globally, or even within a given region. Mul-
tiple within-subtype strains would likely be required to produce a vaccine that afforded adequate
protection against most circulating variants using current inactivated vaccine production processes
and application protocols.
Interestingly, H3 viruses circulating in European swine showed lower antigenic diversity than other
regions. This limited antigenic diversity, combined with the use of oil adjuvanted vaccines, could
explain why the prototype A/Port Chalmers/1973 (H3N2)-based vaccine induced protection against
contemporary H3N2 swine influenza viruses isolated up to 35 years later (de Jong et al., 2007;
Van Reeth and Ma, 2013; De Vleeschauwer et al., 2015). However, movement of swine among
geographic regions could lead to the introduction of novel variants into a new sub-population of
swine despite current import-export quarantine procedures between some countries. Therefore a
more structured approach to vaccine strain selection in swine, where epidemiological, antigenic and
genetic data are considered at a global level by the World Organization for Animal Health (OIE),
similar to the process undertaken for creating equine influenza vaccine recommendations, could pro-
vide an evidence-based rationale for swine vaccine strain selection and improved vaccine efficacy in
swine.
Age-related susceptibility within the human population could be one of the limiting factors in
onward spread of recent human infections with swine viruses. However there remains a need for
focused surveillance in areas with high swine population density and situations where humans and
swine have opportunities for close contact to better assess the incidence of cross-species transmis-
sion and risk of onward transmission within the human population.
Neutralizing immunity to influenza viruses in both humans and swine is largely directed towards
the influenza HA and the antigenic dissimilarity among influenza HAs within and between these two
hosts is undoubtedly important for influenza epidemiology. However, the potential for a virus to
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emerge and spread widely in human or swine populations is likely to be a multi-genic trait compris-
ing factors beyond just antigenicity (Trock et al., 2012). These factors include receptor binding
(Matos-Patro´n et al., 2015; Elderfield et al., 2014), adaptations to the matrix, non-structural, and
neuraminidase proteins (Elderfield et al., 2014) as well as other factors differing between human
and swine influenza viruses yet to be identified. There is also a need to better understand the com-
petition dynamics of different influenza virus variants and subtypes in both human and swine popula-
tions and how these dynamics affect the potential for invasion by novel viruses.
Quantifying the public health risk of circulating swine influenza viruses in terms of immunological
protection could be improved by assessing human population immunity to a selection of the anti-
genically-diverse swine viruses characterized in this study. A globally coordinated and systematic
pipeline of antigenic and genetic analyses of relative antigenic distance between human and swine
strains for subsequent testing of highly divergent swine strains against human sera (age-stratified)
would add valuable information to the current WHO-led emergent pandemic risk assessment and
inform the design of strategic vaccine stockpiles for human populations most at risk of infection with
swine influenza virus, whether by age, geographic location or other factors.
Materials and methods
Viruses
Using hemagglutination inhibition (HI) assays, we characterized the antigenic properties of swine
influenza A H1 and H3 virus strains circulating 1) in Europe, as part of the third program of the Euro-
pean Surveillance Network for Influenza in Pigs (ESNIP3) (www.esnip3.com), and 2) in Asia in collabo-
ration with laboratories in Hong Kong, Japan, Vietnam and Thailand. We also expanded previously
published datasets for North America. To this HI assay dataset we added previously published swine
and human HI assay data for H1 and H3 influenza viruses (Lewis et al., 2014; de Jong et al., 2007;
Lorusso et al., 2011; Koel et al., 2013; Nfon et al., 2011), resulting in an antigenic dataset consist-
ing of 194 swine and human H1 influenza viruses and 379 swine and human H3N2 influenza viruses.
Viruses were propagated in Madin-Darby canine kidney (MDCK) cells or embryonated fowls’
eggs. Harvested cell culture supernatant or allantoic fluid was clarified by centrifugation. For antisera
production virus was concentrated by ultracentrifugation over a 20% w/v sucrose cushion. Virus pel-
lets were resuspended overnight at 4˚C in sterile phosphate buffered saline at pH 7.4 and stored at -
70˚C for use in immunizing naı¨ve pigs.
Swine antisera production
Swine antisera to influenza A viruses were generated by the United States Department of Agriculture
National Animal Disease Centre, Ames, Iowa as previously described (Lorusso et al., 2011). Addi-
tional sera were generated by the French Agency for Food, Environmental and Occupational Health
& Safety, Ploufragan, France, and by the Technical University of Denmark, Copenhagen, Denmark.
To generate these additional antisera each animal was first inoculated intranasally with live influenza
virus (7 to 8 log10 EID50 in a volume of 3 ml; 1.5 ml per nostril). Three weeks later equal volumes of
the same inoculating virus and Freund’s complete adjuvant (total volume 3 ml) or inoculating virus
and Montanide ISA206 (Seppic, Givaudan-Lavirotte, France) (total volume 2 ml) were administered
by intramuscular/intradermal injection The animals were killed and bled two weeks after the last
immunization. For sera raised in the USA, pigs were cared for in compliance with the Institutional
Animal Care and Use Committee of the National Animal Disease Centre and for sera raised in the
EU, all animal work was done in accordance with the local rules and procedures with ethical permis-
sions granted following the codes of practice for performing scientific studies using animals.
Virus antigenic characterization
HI assays using swine antisera were performed to compare the antigenic properties of swine and
human influenza H1 and H3 viruses. Prior to HI testing, sera used for testing most H1 and all H3
viruses were treated with receptor-destroying enzyme (Sigma-Aldrich, MO, USA) and sera used for
testing H1 viruses from the USA were treated with kaolin (Fisher Scientific, Pittsburg, PA, USA). All
sera were then heat inactivated at 56˚C for 30 min and adsorbed with 50% turkey red blood cells
(RBC) to remove nonspecific inhibitors of hemagglutination. HI assays were performed by testing
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reference antisera raised to swine influenza viruses against selected H1 and H3 swine and human
influenza viruses according to standard techniques. Serial 2-fold dilutions starting at 1:10 were
tested for their ability to inhibit the agglutination of 0.5% turkey RBC with four hemagglutinating
units of swine and human H1 and H3 viruses.
Antigenic cartography
To combine HI data generated in different laboratories we used a standard reference panel consist-
ing of viruses and swine antisera raised to selected reference strains and shared among laboratories
(Lewis et al., 2014; Lorusso et al., 2011). Our initial quantitative analyses of the antigenic proper-
ties of swine and human influenza H1 and H3 viruses used antigenic cartography methods as previ-
ously described for human (H3) and swine influenza A (H3) and (H1) viruses (Smith et al., 2004;
Lewis et al., 2014; de Jong et al., 2007; Lorusso et al., 2011; Nfon et al., 2011).
To identify the most appropriate dimensionality of the antigenic maps for each virus subtype, we
made first constructed antigenic maps of H1 and H3 viruses in 1, 2, 3, 4, and 5 dimensions and com-
pared the HI titer differences to the resultant antigenic map distances for each dimension. Increasing
from 1 to 2, and from 2 to 3 dimensions, resulted in significant improvement in correlation between
HI data and map distances indicating that 3 dimensional (3D) maps provide a more accurate repre-
sentation of the underlying HI data (Supplementary file 1). Further increasing map dimensionality
resulted in smaller and statistically insignificant improvements in the quality of the fit of the map to
the underlying HI data. Based on these results, we concluded that 3D maps were sufficient for cap-
turing the antigenic variation of both H1 and H3 viruses in our combined swine and human datasets.
Next we removed a random 10%, 20%, 30%, 40%, and 50% of the HI data and re-made the anti-
genic maps to test the robustness of the antigenic maps and the resolution at which they could visu-
alize antigenic distances among viruses. The precision of point positioning in the 3D antigenic maps
was 0.68 antigenic units (AU) for H1 and 0.85 AU for H3. One AU is equivalent to a two-fold differ-
ence in HI assay titer. Three AUs are considered sufficient antigenic difference to warrant an update
of the human influenza vaccine.
Integrated analysis of antigenic and genetic evolution
For all isolates with both HA sequence data and HI measurements available, we implemented a
Bayesian multidimensional scaling (BMDS) cartographic model to jointly infer antigenic and phyloge-
netic relationships of the viruses as described by Bedford et al. (2014)
In brief, time-resolved phylogenies were estimated for a total of 194 H1 and 379 H3 sequences
using the Bayesian Markov chain Monte Carlo (MCMC) method implemented in
BEAST (Drummond et al., 2012). We incorporated the Hasegawa-Kishino-Yano (HKY) model of
nucleotide substitution model (Hasegawa et al., 1985) with codon partitioning at all three positions,
and a Bayesian Skygrid coalescent model (Gill et al., 2013). A strict molecular clock and an uncorre-
lated lognormal relaxed clock were used for H3 and H1, respectively, based on linear regression
analyses in Path-o-Gen v1.4 (http://tree.bio.ed.ac.uk/software/pathogen/). Ancestral sequence states
were reconstructed using the ‘renaissance counting’ method (Lemey et al., 2012). Two independent
MCMC chains were run for 200 million states with sampling every 20,000 states and a burn-in of 20
million states, and then combined and further subsampled every 180,000 states for a total of 2000
trees after assessing convergence in Tracer v1.6 (http://tree.bio.ed.ac.uk/software/tracer/). Along
with the matching HI measurements for the virus isolates against post-infection ferret and swine anti-
sera, these subsets of 2000 trees were used as an empirical tree distribution for the subsequent
BMDS analysis to simultaneously model antigenic locations and evolutionary history.
The BMDS approach implements a Bayesian analog of antigenic cartographic models from Smith
et al. (Smith et al., 2004) that arrange virus and serum locations in N-dimensions, such that Euclid-
ean distances between locations are inversely proportional to serological cross-reactivity
(Bedford et al., 2014). We generated the antigenic maps by imposing a weakly informative prior on
expected antigenic locations such that antigenic distance increases with sampling time along one
dimension and incorporated genetic data by modelling changes in antigenic phenotype as a diffu-
sion process along the viral phylogeny, i.e. expected virus locations co-vary with genetic relatedness.
Virus avidities and serum potencies were also estimated to account for experimental variation in
serum and virus reactivity. MCMC was used to sample virus and serum locations in either two or
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three antigenic dimensions, as well as virus avidities, serum potencies, antigenic drift rate, MDS pre-
cision, virus and serum location precisions, and phylogenetic patterns. MCMC chains were run for
500 million states with sampling every 200,000 states, and checked for convergence by high ESS val-
ues in Tracer. Following burn-in of 100 million states, we obtained a total of 2,000 trees from which
the maximum clade credibility tree was summarized in TreeAnnotator v1.8.2.
We used TimeSlicer available in SPREAD (Bielejec et al., 2011) to quantify the rates of antigenic
evolution and levels of standing diversity over the posterior distribution of trees. This was achieved
by ‘slicing’ through the BMDS-derived antigenic map location-tagged phylogenies at year-intervals,
imputing the unobserved ancestral antigenic locations for branches that intersect those time points,
and summarizing the drift front distance (in AU) from the most recent common ancestor (MRCA) and
the mean pairwise distance between locations (in AU) for each lineage at that slice time. The overall
antigenic drift rate was calculated by taking the total imputed drift front distance from the lineage
MRCA divided by the total time elapsed, measured in AU per year. 95% high posterior density
(HPD) estimates were used to measure the uncertainty in these inferences from the posterior sample
of trees.
Other analyses
H1 and H3 influenza A hemagglutinin (HA1) sequences representing the swine reference strains as
well as viruses from swine populations in all available geographic regions were compiled from the
NIAID Influenza Research Database (IRD) through the web site at http://www.fludb.org on 22/9/
2014 (Squires et al., 2012) and combined with then unpublished sequences from European swine
influenza viruses generated as part of the ESNIP3 project (Watson et al., 2015). We added HA1
human seasonal H1 and H3 influenza virus sequences from IRD that represented the entire time
period of the study and all human vaccine strain selections.
Nucleotide alignments of the HA1 domain for both subtypes were generated using default set-
tings in MAFFT with subsequent manual correction. For each alignment the sequences were curated
for poorly curated data by inferring maximum likelihood phylogenetic trees in IQ-Tree
(Nguyen et al., 2015) having performed the model test procedure to select the best-fit model. The
provisional ML trees were then analyzed using Path-O-Gen and outlier sequences in the root-to-tip
regression plots were identified and removed. ML phylogenetic trees were then inferred again using
IQ-TREE as above and ultrafast bootstrap analyses performed (Minh et al., 2013).
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